Xencor to Present at Jefferies 2014 Global Healthcare Conference Read more about Xencor to Present at Jefferies 2014 Global Healthcare Conference
Xencor Presents Study Comparing XmAb7195 to Omalizumab at the American Thoracic Society 2014 International Conference Read more about Xencor Presents Study Comparing XmAb7195 to Omalizumab at the American Thoracic Society 2014 International Conference
Xencor Reports First Quarter 2014 Financial Results Read more about Xencor Reports First Quarter 2014 Financial Results
Xencor to Host First Quarter 2014 Financial Results Webcast and Conference Call Read more about Xencor to Host First Quarter 2014 Financial Results Webcast and Conference Call
Xencor, Inc. to Present at Deutsche Bank 39th Annual Health Care Conference Read more about Xencor, Inc. to Present at Deutsche Bank 39th Annual Health Care Conference
Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 Clinical Trial of a Biologic Candidate using XmAb® Antibody Engineering Intellectual Property Read more about Xencor Receives Milestone Payment from Merck for Initiation of Phase 1 Clinical Trial of a Biologic Candidate using XmAb® Antibody Engineering Intellectual Property
Xencor Showcases Bispecific Antibody Programs at Annual Summit on Practical and Emerging Trends in Multiple Myeloma Read more about Xencor Showcases Bispecific Antibody Programs at Annual Summit on Practical and Emerging Trends in Multiple Myeloma
Xencor to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference Read more about Xencor to Present at 21st Annual BioCentury Future Leaders in the Biotech Industry Conference
Xencor Reports Fourth Quarter and Full Year 2013 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2013 Financial Results
Xencor, Inc. to Host Fourth Quarter and Full Year 2013 Financial Results Webcast and Conference Call Read more about Xencor, Inc. to Host Fourth Quarter and Full Year 2013 Financial Results Webcast and Conference Call
